NeueHealth, Inc. (NEUE)
NYSE: NEUE · Real-Time Price · USD
6.86
+0.02 (0.29%)
Jul 22, 2025, 12:20 PM - Market open
NeueHealth Stock Forecast
Stock Price Forecast
The 1 analyst with a 12-month price forecast for NeueHealth stock has a target of 7, which predicts a 2.12% increase from the current stock price of 6.86.
Price Target: $7 (+2.12%)
Analyst Consensus: Hold
* Price targets were last updated on Dec 9, 2024.
Analyst Ratings
According to 1 stock analyst, the rating for NeueHealth is "Hold". This means that the analyst believes this stock is likely to perform similarly to the overall market.
Recommendation Trends
| Rating | May '25 | Jun '25 | Jul '25 |
|---|---|---|---|
| Strong Buy | 0 | 0 | 0 |
| Buy | 0 | 0 | 0 |
| Hold | 1 | 1 | 1 |
| Sell | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 |
| Total | 1 | 1 | 1 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| RBC Capital | RBC Capital | Hold Maintains $8 → $7 | Hold | Maintains | $8 → $7 | +2.12% | Dec 9, 2024 |
| RBC Capital | RBC Capital | Hold Maintains $7 → $8 | Hold | Maintains | $7 → $8 | +16.70% | Mar 13, 2024 |
Financial Forecast
Revenue This Year
1.26B
from 936.66M
Increased by 33.99%
Revenue Next Year
1.33B
from 1.26B
Increased by 5.90%
EPS This Year
-16.99
from -22.65
EPS Next Year
-14.90
from -16.99
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2025 | 2026 |
|---|---|---|
| High | 1.5B | 1.5B |
| Avg | 1.3B | 1.3B |
| Low | 1.0B | 1.1B |
Revenue Growth
| Revenue Growth | 2025 | 2026 |
|---|---|---|
| High | 56.9% | 21.4% |
| Avg | 34.0% | 5.9% |
| Low | 11.0% | -9.8% |
EPS Forecast
| EPS | 2025 | 2026 |
|---|---|---|
| High | -17.49 | -15.34 |
| Avg | -16.99 | -14.90 |
| Low | -16.33 | -14.32 |
EPS Growth
| EPS Growth | 2025 | 2026 |
|---|---|---|
| High | - | - |
| Avg | - | - |
| Low | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.